BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van Bekkum DW, Roodenburg J, Heidt PJ, van der Waaij D. Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora. J Natl Cancer Inst. 1974;52:401-404. [PMID: 4150164 DOI: 10.1093/jnci/52.2.401] [Cited by in Crossref: 229] [Cited by in F6Publishing: 206] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Lim SH, Patton WN, Jobson S, Gentle TA, Baynham M, Franklin IM, Broughton BJ. Mixed lymphocyte reactions do not predict severity of graft versus host disease (GVHD) in HLA-DR compatible, sibling bone marrow transplants. J Clin Pathol 1988;41:1155-7. [PMID: 2974850 DOI: 10.1136/jcp.41.11.1155] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
2 Simms-Waldrip TR, Sunkersett G, Coughlin LA, Savani MR, Arana C, Kim J, Kim M, Zhan X, Greenberg DE, Xie Y, Davies SM, Koh AY. Antibiotic-Induced Depletion of Anti-inflammatory Clostridia Is Associated with the Development of Graft-versus-Host Disease in Pediatric Stem Cell Transplantation Patients. Biol Blood Marrow Transplant 2017;23:820-9. [PMID: 28192251 DOI: 10.1016/j.bbmt.2017.02.004] [Cited by in Crossref: 78] [Cited by in F6Publishing: 76] [Article Influence: 15.6] [Reference Citation Analysis]
3 Ferrara JL, Krenger W. Graft-versus-host disease: The influence of type 1 and type 2 T cell cytokines. Transfusion Medicine Reviews 1998;12:1-17. [DOI: 10.1016/s0887-7963(98)80085-0] [Cited by in Crossref: 46] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
4 Qayed M, Langston A, Chiang K, August K, Hilinski JA, Cole CR, Rogatko A, Bostick RM, Horan JT. Rifaximin for Preventing Acute Graft-Versus-Host Disease: Impact on Plasma Markers of Inflammation and T-cell Activation. Journal of Pediatric Hematology/Oncology 2013;35:e149-52. [DOI: 10.1097/mph.0b013e31827e56af] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
5 Le Bastard Q, Chevallier P, Montassier E. Gut microbiome in allogeneic hematopoietic stem cell transplantation and specific changes associated with acute graft vs host disease. World J Gastroenterol 2021; 27(45): 7792-7800 [PMID: 34963742 DOI: 10.3748/wjg.v27.i45.7792] [Reference Citation Analysis]
6 Peled JU, Gomes ALC, Devlin SM, Littmann ER, Taur Y, Sung AD, Weber D, Hashimoto D, Slingerland AE, Slingerland JB, Maloy M, Clurman AG, Stein-Thoeringer CK, Markey KA, Docampo MD, Burgos da Silva M, Khan N, Gessner A, Messina JA, Romero K, Lew MV, Bush A, Bohannon L, Brereton DG, Fontana E, Amoretti LA, Wright RJ, Armijo GK, Shono Y, Sanchez-Escamilla M, Castillo Flores N, Alarcon Tomas A, Lin RJ, Yáñez San Segundo L, Shah GL, Cho C, Scordo M, Politikos I, Hayasaka K, Hasegawa Y, Gyurkocza B, Ponce DM, Barker JN, Perales MA, Giralt SA, Jenq RR, Teshima T, Chao NJ, Holler E, Xavier JB, Pamer EG, van den Brink MRM. Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation. N Engl J Med 2020;382:822-34. [PMID: 32101664 DOI: 10.1056/NEJMoa1900623] [Cited by in Crossref: 139] [Cited by in F6Publishing: 87] [Article Influence: 69.5] [Reference Citation Analysis]
7 Malard F, Mohty M. Gut microbiota alteration during allogeneic haematopoietic cell transplantation: what can we do? Br J Haematol 2020;188:351-3. [PMID: 31524291 DOI: 10.1111/bjh.16204] [Reference Citation Analysis]
8 Fredricks DN. The gut microbiota and graft-versus-host disease. Journal of Clinical Investigation 2019;129:1808-17. [DOI: 10.1172/jci125797] [Reference Citation Analysis]
9 Ghimire S, Weber D, Hippe K, Meedt E, Hoepting M, Kattner AS, Hiergeist A, Gessner A, Matos C, Ghimire S, Wolff D, Edinger M, Hoffmann P, Poeck H, Herr W, Holler E. GPR Expression in Intestinal Biopsies From SCT Patients Is Upregulated in GvHD and Is Suppressed by Broad-Spectrum Antibiotics. Front Immunol 2021;12:753287. [PMID: 34777363 DOI: 10.3389/fimmu.2021.753287] [Reference Citation Analysis]
10 Hanks CR, Slain D, Kanate AS, Wen S, Cumpston A. Impact of anti-anaerobic antibiotic activity on graft-versus-host disease in allogeneic hematopoietic stem cell transplant (HSCT) recipients at an institution that utilizes antibiotic cycling. Transpl Infect Dis 2021;:e13676. [PMID: 34165853 DOI: 10.1111/tid.13676] [Reference Citation Analysis]
11 Whangbo J, Ritz J, Bhatt A. Antibiotic-mediated modification of the intestinal microbiome in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2017;52:183-90. [PMID: 27526283 DOI: 10.1038/bmt.2016.206] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
12 Meedt E, Hiergeist A, Gessner A, Dettmer K, Liebisch G, Ghimire S, Poeck H, Edinger M, Wolff D, Herr W, Holler E, Weber D. Prolonged suppression of butyrate producing bacteria is associated with acute gastrointestinal graft-versus-host disease and transplant related mortality after allogeneic stem cell transplantation. Clin Infect Dis 2021:ciab500. [PMID: 34043764 DOI: 10.1093/cid/ciab500] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Ferrara JL, Cooke KR, Pan L, Krenger W. The immunopathophysiology of acute graft-versus-host-disease. Stem Cells 1996;14:473-89. [PMID: 8888489 DOI: 10.1002/stem.140473] [Cited by in Crossref: 143] [Cited by in F6Publishing: 121] [Article Influence: 5.7] [Reference Citation Analysis]
14 Gratama J, Stijnen T, Weiland H, Hekker A, De Gast G, Zwaan F, Weijers T, D'amaro J, The T, Vossen J. HERPES-VIRUS IMMUNITY AND ACUTE GRAFT-VERSUS-HOST DISEASE. The Lancet 1987;329:471-4. [DOI: 10.1016/s0140-6736(87)92088-5] [Cited by in Crossref: 40] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
15 Hiemenz JW, Pizzo PA. New Developments in the Etiology, Diagnosis, Treatment and Prevention of Infectious Complications in Patients with Leukemia. In: Bloomfield CD, editor. Chronic and Acute Leukemias in Adults. Boston: Springer US; 1985. pp. 283-337. [DOI: 10.1007/978-1-4613-2581-9_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
16 Yu J, Sun H, Cao W, Han L, Song Y, Wan D, Jiang Z. Applications of gut microbiota in patients with hematopoietic stem-cell transplantation. Exp Hematol Oncol 2020;9:35. [PMID: 33292670 DOI: 10.1186/s40164-020-00194-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
17 Bonvalet M, Daillère R, Roberti MP, Rauber C, Zitvogel L. The Impact of the Intestinal Microbiota in Therapeutic Responses Against Cancer. In: Zitvogel L, Kroemer G, editors. Oncoimmunology. Cham: Springer International Publishing; 2018. pp. 447-62. [DOI: 10.1007/978-3-319-62431-0_27] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
18 Teshima T, Reddy P, Zeiser R. Reprint of: Acute Graft-versus-Host Disease: Novel Biological Insights. Biol Blood Marrow Transplant 2016;22:S3-8. [PMID: 26899274 DOI: 10.1016/j.bbmt.2016.01.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
19 Renteria AS, Levine JE, Ferrara JLM. Therapeutic targets and emerging treatment options in gastrointestinal acute graft-versus-host disease. Expert Opin Orphan Drugs 2016;4:469-84. [PMID: 30057862 DOI: 10.1517/21678707.2016.1166949] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
20 Haas RJ, Janka G, Netzel B, Rodt H, Thierfelder S, Helmig M, Eife R, Belohradsky BH, Kolb HJ, Betke K. Antibody incubation of human marrow graft for prevention graft versus host disease. Blut 1980;40:387-97. [DOI: 10.1007/bf01029680] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
21 Koyama M, Hill GR. The primacy of gastrointestinal tract antigen-presenting cells in lethal graft-versus-host disease. Blood. 2019;134:2139-2148. [PMID: 31697827 DOI: 10.1182/blood.2019000823] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 10.5] [Reference Citation Analysis]
22 Vossen JM, Guiot HF, Lankester AC, Vossen AC, Bredius RG, Wolterbeek R, Bakker HD, Heidt PJ. Complete suppression of the gut microbiome prevents acute graft-versus-host disease following allogeneic bone marrow transplantation. PLoS One 2014;9:e105706. [PMID: 25180821 DOI: 10.1371/journal.pone.0105706] [Cited by in Crossref: 67] [Cited by in F6Publishing: 67] [Article Influence: 8.4] [Reference Citation Analysis]
23 Ringdén O, Remberger M, Törlén J, Engström M, Fjaertoft G, Mattsson J, Svahn BM. Home care during neutropenia after allogeneic hematopoietic stem cell transplantation in children and adolescents is safe and may be more advantageous than isolation in hospital. Pediatr Transplant 2014;18:398-404. [PMID: 24802347 DOI: 10.1111/petr.12262] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
24 Shono Y, Docampo MD, Peled JU, Perobelli SM, Jenq RR. Intestinal microbiota-related effects on graft-versus-host disease. Int J Hematol 2015;101:428-37. [PMID: 25812838 DOI: 10.1007/s12185-015-1781-5] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
25 Wu SR, Reddy P. Tissue tolerance: a distinct concept to control acute GVHD severity. Blood 2017;129:1747-52. [PMID: 28153825 DOI: 10.1182/blood-2016-09-740431] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 5.6] [Reference Citation Analysis]
26 Ferrara JL. Pathogenesis of acute graft-versus-host disease: cytokines and cellular effectors. J Hematother Stem Cell Res 2000;9:299-306. [PMID: 10894351 DOI: 10.1089/15258160050079407] [Cited by in Crossref: 121] [Cited by in F6Publishing: 110] [Article Influence: 5.5] [Reference Citation Analysis]
27 Holler E, Butzhammer P, Schmid K, Hundsrucker C, Koestler J, Peter K, Zhu W, Sporrer D, Hehlgans T, Kreutz M. Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease. Biol Blood Marrow Transplant. 2014;20:640-645. [PMID: 24492144 DOI: 10.1016/j.bbmt.2014.01.030] [Cited by in Crossref: 302] [Cited by in F6Publishing: 281] [Article Influence: 37.8] [Reference Citation Analysis]
28 Sadowska-Klasa A, Piekarska A, Prejzner W, Bieniaszewska M, Hellmann A. Colonization with multidrug-resistant bacteria increases the risk of complications and a fatal outcome after allogeneic hematopoietic cell transplantation. Ann Hematol 2018;97:509-17. [PMID: 29255911 DOI: 10.1007/s00277-017-3205-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
29 Biliński J, Jasiński M, Basak GW. The Role of Fecal Microbiota Transplantation in the Treatment of Acute Graft-versus-Host Disease. Biomedicines 2022;10:837. [DOI: 10.3390/biomedicines10040837] [Reference Citation Analysis]
30 Gopalakrishnan V, Helmink BA, Spencer CN, Reuben A, Wargo JA. The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy. Cancer Cell. 2018;33:570-580. [PMID: 29634945 DOI: 10.1016/j.ccell.2018.03.015] [Cited by in Crossref: 371] [Cited by in F6Publishing: 343] [Article Influence: 123.7] [Reference Citation Analysis]
31 Murphy S, Nguyen VH. Role of gut microbiota in graft-versus-host disease. Leukemia & Lymphoma 2011;52:1844-56. [DOI: 10.3109/10428194.2011.580476] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
32 Sullivan KM. Acute and chronic graft-versus-host disease in man. The International Journal of Cell Cloning 1986;4:42-93. [DOI: 10.1002/stem.5530040710] [Cited by in Crossref: 84] [Cited by in F6Publishing: 75] [Article Influence: 2.3] [Reference Citation Analysis]
33 Haralambie E, Schmidt-weinmar A. Infections after experimental cadaver bone marrow transplantation in beagle dogs. Transplantations with and without selective gastrointestinal decontamination. Infection 1988;16:36-41. [DOI: 10.1007/bf01646930] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
34 Kay HEM. Bone Marrow Transplantation in Adult Acute Leukaemia: Who Should Be Transplanted, and When? In: Bloomfield CD, editor. Adult Leukemias 1. Dordrecht: Springer Netherlands; 1982. pp. 381-406. [DOI: 10.1007/978-94-009-7433-3_12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
35 Taur Y. Intestinal microbiome changes and stem cell transplantation: Lessons learned. Virulence. 2016;7:930-938. [PMID: 27805463 DOI: 10.1080/21505594.2016.1250982] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
36 Yoshioka K, Kakihana K, Doki N, Ohashi K. Gut microbiota and acute graft-versus-host disease. Pharmacol Res 2017;122:90-5. [PMID: 28576475 DOI: 10.1016/j.phrs.2017.05.028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
37 Eriguchi Y, Takashima S, Oka H, Shimoji S, Nakamura K, Uryu H, Shimoda S, Iwasaki H, Shimono N, Ayabe T, Akashi K, Teshima T. Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of α-defensins. Blood 2012;120:223-31. [PMID: 22535662 DOI: 10.1182/blood-2011-12-401166] [Cited by in Crossref: 204] [Cited by in F6Publishing: 190] [Article Influence: 20.4] [Reference Citation Analysis]
38 Riwes M, Reddy P. Short chain fatty acids: Postbiotics/metabolites and graft versus host disease colitis. Seminars in Hematology 2020;57:1-6. [DOI: 10.1053/j.seminhematol.2020.06.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
39 Docampo MD, Auletta JJ, Jenq RR. Emerging Influence of the Intestinal Microbiota during Allogeneic Hematopoietic Cell Transplantation: Control the Gut and the Body Will Follow. Biol Blood Marrow Transplant 2015;21:1360-6. [PMID: 25708215 DOI: 10.1016/j.bbmt.2015.02.016] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
40 Truitt RL. The Mortimer M. Bortin lecture. Biology of Blood and Marrow Transplantation 2004;10:505-23. [DOI: 10.1016/j.bbmt.2004.05.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
41 Kornblit B, Müller K. Sensing danger: toll-like receptors and outcome in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2017;52:499-505. [PMID: 27941769 DOI: 10.1038/bmt.2016.263] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
42 Köhler N, Zeiser R. Intestinal Microbiota Influence Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation and Intestinal GVHD. Front Immunol 2018;9:3179. [PMID: 30705680 DOI: 10.3389/fimmu.2018.03179] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
43 Lin D, Hu B, Li P, Zhao Y, Xu Y, Wu D. Roles of the intestinal microbiota and microbial metabolites in acute GVHD. Exp Hematol Oncol 2021;10:49. [PMID: 34706782 DOI: 10.1186/s40164-021-00240-3] [Reference Citation Analysis]
44 Cooke KR, Hill GR, Crawford JM, Bungard D, Brinson YS, Delmonte J Jr, Ferrara JL. Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease. J Clin Invest 1998;102:1882-91. [PMID: 9819375 DOI: 10.1172/JCI4285] [Cited by in Crossref: 258] [Cited by in F6Publishing: 121] [Article Influence: 10.8] [Reference Citation Analysis]
45 Fredricks DN. The gut microbiota and graft-versus-host disease. J Clin Invest 2019;129:1808-17. [PMID: 31042160 DOI: 10.1172/JCI125797] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 11.3] [Reference Citation Analysis]
46 Bostrom L, Ringden O, Forsgren M. Strong Donor Mononuclear Cell Reactivity for Herpes Simplex Virus (HSV) Antigen in HSV Immune Donors Combined with Recipient Seropositivity for HSV is Associated with Acute Graft-versus-Host Disease. Scand J Immunol 1991;34:45-53. [DOI: 10.1111/j.1365-3083.1991.tb01519.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
47 Bossù G, Di Sario R, Argentiero A, Esposito S. Antimicrobial Prophylaxis and Modifications of the Gut Microbiota in Children with Cancer. Antibiotics (Basel) 2021;10:152. [PMID: 33546312 DOI: 10.3390/antibiotics10020152] [Reference Citation Analysis]
48 Appelbaum FR. Choosing the Source of Stem Cells for Allogeneic Transplantation: No Longer a Peripheral Issue. Blood 1999;94:381-3. [DOI: 10.1182/blood.v94.2.381] [Cited by in Crossref: 25] [Article Influence: 1.1] [Reference Citation Analysis]
49 Bowerman KL, Varelias A, Lachner N, Kuns RD, Hill GR, Hugenholtz P. Continuous pre- and post-transplant exposure to a disease-associated gut microbiome promotes hyper-acute graft-versus-host disease in wild-type mice. Gut Microbes 2020;11:754-70. [PMID: 31928131 DOI: 10.1080/19490976.2019.1705729] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
50 Chao NJ. Pharmacologic Prevention of Acute Graft-versus-Host Disease. In: Forman SJ, Negrin RS, Antin JH, Appelbaum FR, editors. Thomas’ Hematopoietic Cell Transplantation. Chichester: John Wiley & Sons, Ltd; 2015. pp. 990-1006. [DOI: 10.1002/9781118416426.ch81] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Zhang P, Hill GR. Interleukin-10 mediated immune regulation after stem cell transplantation: Mechanisms and implications for therapeutic intervention. Semin Immunol 2019;44:101322. [PMID: 31640914 DOI: 10.1016/j.smim.2019.101322] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
52 Cooke KR, Gerbitz A, Crawford JM, Teshima T, Hill GR, Tesolin A, Rossignol DP, Ferrara JL. LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation. J Clin Invest 2001;107:1581-9. [PMID: 11413166 DOI: 10.1172/JCI12156] [Cited by in Crossref: 221] [Cited by in F6Publishing: 98] [Article Influence: 10.5] [Reference Citation Analysis]
53 Nguyen CL, Docampo MD, van den Brink MR, Markey KA. The role of the intestinal microbiota in allogeneic HCT: clinical associations and preclinical mechanisms. Curr Opin Genet Dev 2021;66:25-35. [PMID: 33388483 DOI: 10.1016/j.gde.2020.11.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Vossen JM, Heidt PJ, van den Berg H, Gerritsen EJ, Hermans J, Dooren LJ. Prevention of infection and graft-versus-host disease by suppression of intestinal microflora in children treated with allogeneic bone marrow transplantation. Eur J Clin Microbiol Infect Dis 1990;9:14-23. [PMID: 2105890 DOI: 10.1007/BF01969527] [Cited by in Crossref: 93] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
55 Holler E. The Role of Innate Immunity in Graft-Versus-Host Disease and Complications following Allogeneic Stem Cell Transplant. Biology of Blood and Marrow Transplantation 2009;15:59-61. [DOI: 10.1016/j.bbmt.2008.10.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
56 Eriguchi Y, Nakamura K, Hashimoto D, Shimoda S, Shimono N, Akashi K, Ayabe T, Teshima T. Decreased secretion of Paneth cell α-defensins in graft-versus-host disease. Transpl Infect Dis 2015;17:702-6. [PMID: 26198302 DOI: 10.1111/tid.12423] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 5.1] [Reference Citation Analysis]
57 Srinivasan R, Chakrabarti S, Walsh T, Igarashi T, Takahashi Y, Kleiner D, Donohue T, Shalabi R, Carvallo C, Barrett AJ, Geller N, Childs R. Improved survival in steroid-refractory acute graft versus host disease after non-myeloablative allogeneic transplantation using a daclizumab-based strategy with comprehensive infection prophylaxis. Br J Haematol 2004;124:777-86. [PMID: 15009066 DOI: 10.1111/j.1365-2141.2004.04856.x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 62] [Article Influence: 3.8] [Reference Citation Analysis]
58 DeFilipp Z, Hohmann E, Jenq RR, Chen YB. Fecal Microbiota Transplantation: Restoring the Injured Microbiome after Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant 2019;25:e17-22. [PMID: 30408565 DOI: 10.1016/j.bbmt.2018.10.022] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 6.8] [Reference Citation Analysis]
59 Schaefer UW, Beelen DW, Mahmoud HK, Quabeck K, Becher R, Schmidt CG, Bamberg M, Quast U, Haralambie E, Linzenmeier G, Stollmann B, Grosse-wilde H, Richter HJ, Hantschke D, Henneberg K, Luboldt W. Bone Marrow Transplantation in Acute Leukemia. In: Büchner T, Schellong G, Hiddemann W, Urbanitz D, Ritter J, editors. Acute Leukemias. Berlin: Springer Berlin Heidelberg; 1987. pp. 213-6. [DOI: 10.1007/978-3-642-71213-5_31] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
60 Vriesendorp HM, Bijnen AB, Kessel ACM, Obertop H, Westbroek DL. Minor Histocompatibility Systems in Dogs. In: Baum SJ, Ledney GD, editors. Experimental Hematology Today 1978. New York: Springer; 1978. pp. 109-17. [DOI: 10.1007/978-1-4612-6304-3_12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
61 Svahn BM, Remberger M, Heijbel M, Martell E, Wikström M, Eriksson B, Milovsavljevic R, Mattsson J, Ringdén O. Case-control comparison of at-home and hospital care for allogeneic hematopoietic stem-cell transplantation: the role of oral nutrition. Transplantation 2008;85:1000-7. [PMID: 18408581 DOI: 10.1097/TP.0b013e31816a3267] [Cited by in Crossref: 33] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
62 Ferrara JLM, Cooke KR, Teshima T. The Pathophysiology of Acute Graft-versus-Host Disease. Int J Hematol 2003;78:181-7. [DOI: 10.1007/bf02983793] [Cited by in Crossref: 148] [Cited by in F6Publishing: 45] [Article Influence: 7.8] [Reference Citation Analysis]
63 Christensen ME, Sinfield LJ, Cullup H, Waterhouse NJ, Atkinson K, Rice AM. Environmental conditions are important for establishing and evaluating pre-clinical models of GVHD. Bone Marrow Transplant 2012;47:607-9. [PMID: 21706062 DOI: 10.1038/bmt.2011.128] [Reference Citation Analysis]
64 Mathewson N, Reddy P. The Microbiome and Graft Versus Host Disease. Curr Stem Cell Rep 2015;1:39-47. [DOI: 10.1007/s40778-014-0002-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 1.9] [Reference Citation Analysis]
65 Chao NJ. Graft versus host disease following allogeneic bone marrow transplantation. Current Opinion in Immunology 1992;4:571-6. [DOI: 10.1016/0952-7915(92)90028-d] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
66 Yunis E, Awdeh Z, Raum D, Alper C. The MHC in human bone marrow allotransplantation. Clinics in Haematology 1983;12:641-80. [DOI: 10.1016/s0308-2261(83)80004-6] [Cited by in Crossref: 7] [Article Influence: 0.2] [Reference Citation Analysis]
67 van der Velden WJ, Herbers AH, Netea MG, Blijlevens NM. Mucosal barrier injury, fever and infection in neutropenic patients with cancer: introducing the paradigm febrile mucositis. Br J Haematol. 2014;167:441-452. [PMID: 25196917 DOI: 10.1111/bjh.13113] [Cited by in Crossref: 64] [Cited by in F6Publishing: 54] [Article Influence: 8.0] [Reference Citation Analysis]
68 Antin JH. Relationship Between Intestinal Bacteria and the Anticancer Effect of Hematopoietic Stem-Cell Transplantation. J Clin Oncol 2017;35:1636-7. [PMID: 28296583 DOI: 10.1200/JCO.2017.72.2603] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
69 Perobelli SM, Silva TG, Bonomo A. Neutrophils Plasticity: The Regulatory Interface in Various Pathological Conditions. In: Khajah MA, editor. Role of Neutrophils in Disease Pathogenesis. InTech; 2017. [DOI: 10.5772/68130] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
70 Peled JU, Hanash AM, Jenq RR. Role of the intestinal mucosa in acute gastrointestinal GVHD. Blood. 2016;128:2395-2402. [PMID: 27856471 DOI: 10.1182/blood-2016-06-716738] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
71 Pessach I, Tsirigotis P, Nagler A. The gastrointestinal tract: properties and role in allogeneic hematopoietic stem cell transplantation. Expert Rev Hematol 2017;10:315-26. [PMID: 28136133 DOI: 10.1080/17474086.2017.1288566] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
72 Rozendaal L, Pals ST, Melief CJ, Gleichmann E. Protection from lethal graft-vs.-host disease by donor stem cell repopulation. Eur J Immunol 1992;22:575-9. [PMID: 1347016 DOI: 10.1002/eji.1830220241] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
73 Hong R, Ammann AJ. CUTANEOUS SIGNALS OF HOST-DEFENSE FAILURE. Int J Dermatol 1977;16:627-39. [DOI: 10.1111/j.1365-4362.1977.tb01873.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
74 Otegbeye F, Gale RP, Lazarus HM. Autologous GVHD? Bone Marrow Transplant 2014;49:1349-51. [PMID: 25089596 DOI: 10.1038/bmt.2014.169] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
75 Boieri M, Shah P, Dressel R, Inngjerdingen M. The Role of Animal Models in the Study of Hematopoietic Stem Cell Transplantation and GvHD: A Historical Overview. Front Immunol. 2016;7:333. [PMID: 27625651 DOI: 10.3389/fimmu.2016.00333] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
76 Holler E, Rogler G, Brenmoehl J, Hahn J, Greinix H, Dickinson AM, Socie G, Wolff D, Finke J, Fischer G, Jackson G, Rocha V, Hilgendorf I, Eissner G, Marienhagen J, Andreesen R. The role of genetic variants of NOD2/CARD15, a receptor of the innate immune system, in GvHD and complications following related and unrelated donor haematopoietic stem cell transplantation. Int J Immunogenet 2008;35:381-4. [PMID: 18976442 DOI: 10.1111/j.1744-313X.2008.00795.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
77 Klimczak A, Lange A. Th17 mediated alloreactivity is facilitated by the pre-transplant microbial burden of the recipient. Bone Marrow Res. 2012;2012:960280. [PMID: 23091728 DOI: 10.1155/2012/960280] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
78 Pals ST, Radaszkiewicz T, Gleichmann E. Induction of either acute or chronic graft-versus-host disease due to genetic differences among donor T cells. Adv Exp Med Biol 1982;149:537-44. [PMID: 6216769 DOI: 10.1007/978-1-4684-9066-4_75] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
79 Ghanem S, Kim CJ, Dutta D, Salifu M, Lim SH. Antimicrobial therapy during cancer treatment: Beyond antibacterial effects. J Intern Med 2021;290:40-56. [PMID: 33372309 DOI: 10.1111/joim.13238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Gale RP. Graft-versus-Host Disease. Immunol Rev 1985;88:193-214. [DOI: 10.1111/j.1600-065x.1985.tb01159.x] [Cited by in Crossref: 77] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
81 Imado T, Iwasaki T, Kitano S, Satake A, Kuroiwa T, Tsunemi S, Sano H. The protective role of host Toll-like receptor-4 in acute graft-versus-host disease. Transplantation 2010;90:1063-70. [PMID: 20975627 DOI: 10.1097/TP.0b013e3181f86947] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
82 John Barrett A, Joseph Melenhorst J. Is human cell therapy research caught in a mousetrap? Mol Ther 2011;19:224-7. [PMID: 21289634 DOI: 10.1038/mt.2010.304] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
83 Sung AD, Chao NJ. Acute graft-versus-host disease: are we close to bringing the bench to the bedside? Best Pract Res Clin Haematol 2013;26:285-92. [PMID: 24309532 DOI: 10.1016/j.beha.2013.10.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
84 Khoruts A, Hippen KL, Lemire AM, Holtan SG, Knights D, Young JH. Toward revision of antimicrobial therapies in hematopoietic stem cell transplantation: target the pathogens, but protect the indigenous microbiota. Transl Res 2017;179:116-25. [PMID: 27513211 DOI: 10.1016/j.trsl.2016.07.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
85 Calcaterra C, Sfondrini L, Rossini A, Sommariva M, Rumio C, Ménard S, Balsari A. Critical Role of TLR9 in Acute Graft-versus-Host Disease. J Immunol 2008;181:6132-9. [DOI: 10.4049/jimmunol.181.9.6132] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 4.0] [Reference Citation Analysis]
86 Bouchlaka MN, Redelman D, Murphy WJ. Immunotherapy following hematopoietic stem cell transplantation: potential for synergistic effects. Immunotherapy 2010;2:399-418. [PMID: 20635904 DOI: 10.2217/imt.10.20] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
87 Landfried K, Bataille F, Rogler G, Brenmoehl J, Kosovac K, Wolff D, Hilgendorf I, Hahn J, Edinger M, Hoffmann P, Obermeier F, Schoelmerich J, Andreesen R, Holler E. Recipient NOD2/CARD15 status affects cellular infiltrates in human intestinal graft-versus-host disease. Clin Exp Immunol 2010;159:87-92. [PMID: 19912254 DOI: 10.1111/j.1365-2249.2009.04049.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
88 van der Velden WJ, Netea MG, de Haan AF, Huls GA, Donnelly JP, Blijlevens NM. Role of the mycobiome in human acute graft-versus-host disease. Biol Blood Marrow Transplant 2013;19:329-32. [PMID: 23160005 DOI: 10.1016/j.bbmt.2012.11.008] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 6.1] [Reference Citation Analysis]
89 August KJ, Chiang KY, Qayed M, Dulson A, Worthington-White D, Cole CR, Horan JT. Relative defects in mucosal immunity predict acute graft-versus-host disease. Biol Blood Marrow Transplant 2014;20:1056-9. [PMID: 24641826 DOI: 10.1016/j.bbmt.2014.03.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
90 Martin PJ, Hansen JA, Storb R, Thomas ED. Human marrow transplantation: an immunological perspective. Adv Immunol 1987;40:379-438. [PMID: 2884832 DOI: 10.1016/s0065-2776(08)60243-6] [Cited by in Crossref: 81] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
91 Sangiorgi B, Panepucci RA. Modulation of Immunoregulatory Properties of Mesenchymal Stromal Cells by Toll-Like Receptors: Potential Applications on GVHD. Stem Cells Int. 2016;2016:9434250. [PMID: 27738438 DOI: 10.1155/2016/9434250] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
92 Eissner G, Lindner H, Behrends U, Kölch W, Hieke A, Klauke I, Bornkamm GW, Holler E. Influence of bacterial endotoxin on radiation-induced activation of human endothelial cells in vitro and in vivo: protective role of IL-10. Transplantation 1996;62:819-27. [PMID: 8824483 DOI: 10.1097/00007890-199609270-00020] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 1.2] [Reference Citation Analysis]
93 Rafei H, Jenq RR. Microbiome-intestine cross talk during acute graft-versus-host disease. Blood 2020;136:401-9. [PMID: 32526029 DOI: 10.1182/blood.2019000950] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
94 Gorkiewicz G, Moschen A. Gut microbiome: a new player in gastrointestinal disease. Virchows Archiv : an international journal of pathology. 2018;472:159-172. [PMID: 29243124 DOI: 10.1007/s00428-017-2277-x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 7.4] [Reference Citation Analysis]
95 Watson JG. Problems of infection after bone marrow transplantation. J Clin Pathol 1983;36:683-92. [PMID: 6304151 DOI: 10.1136/jcp.36.6.683] [Cited by in Crossref: 79] [Cited by in F6Publishing: 67] [Article Influence: 2.0] [Reference Citation Analysis]
96 Vandenhove B, Canti L, Schoemans H, Beguin Y, Baron F, Graux C, Kerre T, Servais S. How to Make an Immune System and a Foreign Host Quickly Cohabit in Peace? The Challenge of Acute Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation. Front Immunol 2020;11:583564. [PMID: 33193397 DOI: 10.3389/fimmu.2020.583564] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
97 Trenschel R, Peceny R, Runde V, Elmaagacli A, Dermoumi H, Heintschel von Heinegg E, Müller KD, Schaefer UW, Beelen DW. Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination. Bone Marrow Transplant 2000;26:993-7. [PMID: 11100279 DOI: 10.1038/sj.bmt.1702655] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
98 Meyers JD. Infection in bone marrow transplant recipients. The American Journal of Medicine 1986;81:27-38. [DOI: 10.1016/0002-9343(86)90511-5] [Cited by in Crossref: 119] [Cited by in F6Publishing: 100] [Article Influence: 3.3] [Reference Citation Analysis]
99 Jasperson LK, Bucher C, Panoskaltsis-Mortari A, Mellor AL, Munn DH, Blazar BR. Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality. Blood 2009;114:5062-70. [PMID: 19828695 DOI: 10.1182/blood-2009-06-227587] [Cited by in Crossref: 96] [Cited by in F6Publishing: 91] [Article Influence: 7.4] [Reference Citation Analysis]
100 Heidegger S, van den Brink MR, Haas T, Poeck H. The role of pattern-recognition receptors in graft-versus-host disease and graft-versus-leukemia after allogeneic stem cell transplantation. Front Immunol 2014;5:337. [PMID: 25101080 DOI: 10.3389/fimmu.2014.00337] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 5.5] [Reference Citation Analysis]
101 Buckley RH. Immunoreconstitution. Pediatric Clinics of North America 1977;24:313-28. [DOI: 10.1016/s0031-3955(16)33421-6] [Cited by in Crossref: 11] [Article Influence: 0.2] [Reference Citation Analysis]
102 Chen Y, Zhao Y, Cheng Q, Wu D, Liu H. The Role of Intestinal Microbiota in Acute Graft-versus-Host Disease. J Immunol Res 2015;2015:145859. [PMID: 26090477 DOI: 10.1155/2015/145859] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
103 Rogers MJ, Moore R, Cohen J. The relationship between faecal endotoxin and faecal microflora of the C57BL mouse. J Hyg (Lond) 1985;95:397-402. [PMID: 4067295 DOI: 10.1017/s0022172400062823] [Cited by in Crossref: 22] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
104 Galvani RG, Lemos R, Areal RB, Salvador PA, Zamboni DS, Wanderley JL, Bonomo A. Disease severity and mortality can be independently regulated in a mouse model of experimental graft versus host disease. PLoS One 2015;10:e0118079. [PMID: 25643148 DOI: 10.1371/journal.pone.0118079] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
105 Mohamed FA, Thangavelu G, Rhee SY, Sage PT, O'Connor RS, Rathmell JC, Blazar BR. Recent Metabolic Advances for Preventing and Treating Acute and Chronic Graft Versus Host Disease. Front Immunol 2021;12:757836. [PMID: 34712243 DOI: 10.3389/fimmu.2021.757836] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Chao NJ, Chen BJ. Prophylaxis and treatment of acute graft-versus-host disease. Semin Hematol 2006;43:32-41. [PMID: 16412787 DOI: 10.1053/j.seminhematol.2005.09.007] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
107 Beelen DW, Quabeck K, Mahmoud HK, Schaefer UW, Becher R, Schmidt CG, Bamberg M, Quast U, Grosse-wilde H, Haralambie E, Linzenmeier G, Stollmann B, Richter HJ, Hantschke D, Thraenhardt O, Henneberg-quester K, Luboldt W. Allogeneic bone marrow transplantation for acute leukaemia or chronic myeloid leukaemia in the fifth decade of life. European Journal of Cancer and Clinical Oncology 1987;23:1665-71. [DOI: 10.1016/0277-5379(87)90447-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
108 Marr KA, Seidel K, Slavin MA, Bowden RA, Schoch HG, Flowers MED, Corey L, Boeckh M. Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial. Blood 2000;96:2055-61. [DOI: 10.1182/blood.v96.6.2055] [Cited by in Crossref: 376] [Article Influence: 17.1] [Reference Citation Analysis]
109 Jenq RR, Taur Y, Devlin SM, Ponce DM, Goldberg JD, Ahr KF, Littmann ER, Ling L, Gobourne AC, Miller LC, Docampo MD, Peled JU, Arpaia N, Cross JR, Peets TK, Lumish MA, Shono Y, Dudakov JA, Poeck H, Hanash AM, Barker JN, Perales MA, Giralt SA, Pamer EG, van den Brink MR. Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease. Biol Blood Marrow Transplant 2015;21:1373-83. [PMID: 25977230 DOI: 10.1016/j.bbmt.2015.04.016] [Cited by in Crossref: 355] [Cited by in F6Publishing: 341] [Article Influence: 50.7] [Reference Citation Analysis]
110 Singh HP, Gupta S, Raju GM, Kochupillai V. Redefining 'self': the role of microflora (commensals) mismatch in the development of GvHD after allogeneic stem cell transplantation and some possible remedies. Med Hypotheses 2001;56:448-50. [PMID: 11339845 DOI: 10.1054/mehy.2000.1197] [Reference Citation Analysis]
111 Shaw MH, Kamada N, Warner N, Kim YG, Nuñez G. The ever-expanding function of NOD2: autophagy, viral recognition, and T cell activation. Trends Immunol 2011;32:73-9. [PMID: 21251876 DOI: 10.1016/j.it.2010.12.007] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 4.7] [Reference Citation Analysis]
112 Staffas A, Burgos da Silva M, van den Brink MR. The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease. Blood 2017;129:927-33. [PMID: 27940475 DOI: 10.1182/blood-2016-09-691394] [Cited by in Crossref: 95] [Cited by in F6Publishing: 97] [Article Influence: 15.8] [Reference Citation Analysis]
113 Koide S, McVay LD, Frankel WL, Behling CA, Zhou ED, Shimada T, Zhang W, Rombeau JL. Increased expression of tissue cytokines in graft-versus-host disease after small bowel transplantation in the rat. Transplantation. 1997;64:518-524. [PMID: 9275121 DOI: 10.1097/00007890-199708150-00023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
114 Shono Y, Docampo MD, Peled JU, Perobelli SM, Velardi E, Tsai JJ, Slingerland AE, Smith OM, Young LF, Gupta J, Lieberman SR, Jay HV, Ahr KF, Porosnicu Rodriguez KA, Xu K, Calarfiore M, Poeck H, Caballero S, Devlin SM, Rapaport F, Dudakov JA, Hanash AM, Gyurkocza B, Murphy GF, Gomes C, Liu C, Moss EL, Falconer SB, Bhatt AS, Taur Y, Pamer EG, van den Brink MRM, Jenq RR. Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice. Sci Transl Med 2016;8:339ra71. [PMID: 27194729 DOI: 10.1126/scitranslmed.aaf2311] [Cited by in Crossref: 248] [Cited by in F6Publishing: 241] [Article Influence: 49.6] [Reference Citation Analysis]
115 Ferrara JL, Harris AC, Greenson JK, Braun TM, Holler E, Teshima T, Levine JE, Choi SW, Huber E, Landfried K, Akashi K, Vander Lugt M, Reddy P, Chin A, Zhang Q, Hanash S, Paczesny S. Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease. Blood. 2011;118:6702-6708. [PMID: 21979939 DOI: 10.1182/blood-2011-08-375006] [Cited by in Crossref: 206] [Cited by in F6Publishing: 199] [Article Influence: 18.7] [Reference Citation Analysis]
116 Heit H, Heit W, Kohne E, Fliedner TM, Hughes P. Allogeneic bone marrow transplantation in conventional mice: I. Effect of antibiotic therapy on long term survival of allogeneic chimeras. Blut 1977;35:143-53. [PMID: 20185 DOI: 10.1007/BF00996294] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
117 Sato S, Shimizu E, He J, Ogawa M, Asai K, Yazu H, Rusch R, Yamane M, Yang F, Fukuda S, Kawakami Y, Tsubota K, Ogawa Y. Positive Effects of Oral Antibiotic Administration in Murine Chronic Graft-Versus-Host Disease. Int J Mol Sci 2021;22:3745. [PMID: 33916809 DOI: 10.3390/ijms22073745] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
118 Sabihi M, Böttcher M, Pelczar P, Huber S. Microbiota-Dependent Effects of IL-22. Cells 2020;9:E2205. [PMID: 33003458 DOI: 10.3390/cells9102205] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
119 Kolb HJ. Allogeneic bone marrow transplantation in leukemia. Recent Results Cancer Res 1984;93:269-89. [PMID: 6382484 DOI: 10.1007/978-3-642-82249-0_12] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
120 Korngold R, Antin JH. Biology and management of acute graft-versus-host disease. Cancer Treat Res 2009;144:257-75. [PMID: 19779886 DOI: 10.1007/978-0-387-78580-6_11] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
121 Peled JU, Jenq RR, Holler E, van den Brink MR. Role of gut flora after bone marrow transplantation. Nat Microbiol 2016;1:16036. [PMID: 27572448 DOI: 10.1038/nmicrobiol.2016.36] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
122 Penack O, Holler E, van den Brink MR. Graft-versus-host disease: regulation by microbe-associated molecules and innate immune receptors. Blood. 2010;115:1865-1872. [PMID: 20042727 DOI: 10.1182/blood-2009-09-242784] [Cited by in Crossref: 113] [Cited by in F6Publishing: 105] [Article Influence: 8.7] [Reference Citation Analysis]
123 Truitt RL. Use of Decontamination and a Protected Environment to Prevent Secondary Disease Following Adoptive Immunotherapy of Acute Leukemia in Mice. In: Baum SJ, Ledney GD, editors. Experimental Hematology Today 1978. New York: Springer; 1978. pp. 195-201. [DOI: 10.1007/978-1-4612-6304-3_24] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
124 Ferrara JL, Antin JH. The Pathophysiology of Graft-versus-Host Disease. In: Forman SJ, Negrin RS, Antin JH, Appelbaum FR, editors. Thomas’ Hematopoietic Cell Transplantation. Chichester: John Wiley & Sons, Ltd; 2015. pp. 146-55. [DOI: 10.1002/9781118416426.ch13] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
125 Mowat AM. Intestinal graft-versus-host disease. In: Macdonald TT, editor. Immunology of Gastrointestinal Disease. Dordrecht: Springer Netherlands; 1992. pp. 105-36. [DOI: 10.1007/978-94-011-2978-7_7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
126 Skelton J, Pizzo PA. Problems of intensive therapy in childhood cancer. Cancer 1986;58:488-503. [DOI: 10.1002/1097-0142(19860715)58:2+<488::aid-cncr2820581313>3.0.co;2-f] [Cited by in Crossref: 7] [Article Influence: 0.2] [Reference Citation Analysis]
127 Alonso CD, Braun DA, Patel I, Akbari M, Oh DJ, Jun T, McMasters M, Hammond SP, Glotzbecker B, Cutler C, Leffler DA, Ballen KK, Kelly CP. A multicenter, retrospective, case-cohort study of the epidemiology and risk factors for Clostridium difficile infection among cord blood transplant recipients. Transpl Infect Dis 2017;19. [PMID: 28544102 DOI: 10.1111/tid.12728] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
128 Bortin MM. Allogeneic bone marrow transplantation in leukemia patients. Curr Probl Cancer 1986;10:1-52. [PMID: 3512175 DOI: 10.1016/s0147-0272(86)80011-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
129 van Bekkum DW. Summing up In Perspective. In: Thierfelder S, Rodt H, Kolb HJ, editors. Immunobiology of Bone Marrow Transplantation. Berlin: Springer Berlin Heidelberg; 1980. pp. 419-30. [DOI: 10.1007/978-3-642-67319-1_37] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
130 van Bekkum DW, Löwenberg B, Vriesendorp HM. Bone Marrow Transplantation. In: Jirsch DW, editor. Immunological Engineering. Dordrecht: Springer Netherlands; 1978. pp. 179-227. [DOI: 10.1007/978-94-011-6182-4_6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
131 Hauser H, Zach O, Krieger O, Kasparu H, Koenig J, Girschikofsky M, Oberbauer R, Lutz D. A single nucleotide polymorphism at chromosome 2q21.3 (LCT -13910C>T) associates with clinical outcome after allogeneic hematopoietic stem cell transplantation. Blood 2008;112:2156-9. [PMID: 18544679 DOI: 10.1182/blood-2008-02-139766] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
132 Bryson JS, Brandon JA, Jennings CD, Kaplan AM. A gut feeling about murine syngeneic GVHD. Chimerism 2011;2:58-60. [PMID: 21912721 DOI: 10.4161/chim.2.2.16783] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
133 Brandon JA, Jennings CD, Kaplan AM, Bryson JS. Murine Syngeneic Graft-Versus-Host Disease Is Responsive to Broad-Spectrum Antibiotic Therapy. J I 2011;186:3726-34. [DOI: 10.4049/jimmunol.1003343] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
134 Shallis RM, Terry CM, Lim SH. Changes in intestinal microbiota and their effects on allogeneic stem cell transplantation. Am J Hematol 2018;93:122-8. [PMID: 28842931 DOI: 10.1002/ajh.24896] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
135 Qayed M, Michonneau D, Socié G, Waller EK. Indole derivatives, microbiome and graft versus host disease. Curr Opin Immunol 2021;70:40-7. [PMID: 33647539 DOI: 10.1016/j.coi.2021.02.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
136 Sung AD, Chao NJ. Concise review: acute graft-versus-host disease: immunobiology, prevention, and treatment. Stem Cells Transl Med. 2013;2:25-32. [PMID: 23283494 DOI: 10.5966/sctm.2012-0115] [Cited by in Crossref: 81] [Cited by in F6Publishing: 74] [Article Influence: 8.1] [Reference Citation Analysis]
137 Beelen DW, Elmaagacli A, Müller K, Hirche H, Schaefer UW. Influence of Intestinal Bacterial Decontamination Using Metronidazole and Ciprofloxacin or Ciprofloxacin Alone on the Development of Acute Graft-Versus-Host Disease After Marrow Transplantation in Patients With Hematologic Malignancies: Final Results and Long-Term Follow-Up of an Open-Label Prospective Randomized Trial. Blood 1999;93:3267-75. [DOI: 10.1182/blood.v93.10.3267.410k22_3267_3275] [Cited by in Crossref: 200] [Article Influence: 8.7] [Reference Citation Analysis]
138 Weber D, Oefner PJ, Dettmer K, Hiergeist A, Koestler J, Gessner A, Weber M, Stämmler F, Hahn J, Wolff D, Herr W, Holler E. Rifaximin preserves intestinal microbiota balance in patients undergoing allogeneic stem cell transplantation. Bone Marrow Transplant 2016;51:1087-92. [PMID: 26999466 DOI: 10.1038/bmt.2016.66] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 10.2] [Reference Citation Analysis]
139 Andermann TM, Peled JU, Ho C, Reddy P, Riches M, Storb R, Teshima T, van den Brink MRM, Alousi A, Balderman S, Chiusolo P, Clark WB, Holler E, Howard A, Kean LS, Koh AY, McCarthy PL, McCarty JM, Mohty M, Nakamura R, Rezvani K, Segal BH, Shaw BE, Shpall EJ, Sung AD, Weber D, Whangbo J, Wingard JR, Wood WA, Perales MA, Jenq RR, Bhatt AS; Blood and Marrow Transplant Clinical Trials Network. The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future. Biol Blood Marrow Transplant 2018;24:1322-40. [PMID: 29471034 DOI: 10.1016/j.bbmt.2018.02.009] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 11.3] [Reference Citation Analysis]
140 Tawara I, Liu C, Tamaki H, Toubai T, Sun Y, Evers R, Nieves E, Mathewson N, Nunez G, Reddy P. Influence of donor microbiota on the severity of experimental graft-versus-host-disease. Biol Blood Marrow Transplant 2013;19:164-8. [PMID: 22982686 DOI: 10.1016/j.bbmt.2012.09.001] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
141 Osman AEG, Luke JJ. The Impact of the Fecal Microbiome on Cancer Immunotherapy. BioDrugs 2019;33:1-7. [PMID: 30604388 DOI: 10.1007/s40259-018-0328-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
142 Ara T, Hashimoto D. Novel Insights Into the Mechanism of GVHD-Induced Tissue Damage. Front Immunol 2021;12:713631. [PMID: 34512636 DOI: 10.3389/fimmu.2021.713631] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
143 van der Waart AB, van der Velden WJ, Blijlevens NM, Dolstra H. Targeting the IL17 Pathway for the Prevention of Graft-Versus-Host Disease. Biology of Blood and Marrow Transplantation 2014;20:752-9. [DOI: 10.1016/j.bbmt.2014.02.007] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
144 Cooke KR, Olkiewicz K, Erickson N, Ferrara JL. The role of endotoxin and the innate immune response in the pathophysiology of acute graft versus host disease. Journal of Endotoxin Research 2002;8:441-8. [DOI: 10.1177/09680519020080061301] [Cited by in Crossref: 32] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
145 Gałązka P, Styczyński J, Czyżewski K, Salamonowicz-Bodzioch M, Frączkiewicz J, Zając-Spychała O, Zaucha-Prażmo A, Goździk J, Biliński J, Basak GW. Impact of decontamination therapy on gastrointestinal acute graft-versus-host disease after allogeneic hematopoietic cell transplantation in children: Decontamination therapy in allo-HCT. Curr Res Transl Med 2021;69:103298. [PMID: 34144374 DOI: 10.1016/j.retram.2021.103298] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
146 Laterza L, Rizzatti G, Gaetani E, Chiusolo P, Gasbarrini A. The Gut Microbiota and Immune System Relationship in Human Graft-versus-Host Disease. Mediterr J Hematol Infect Dis 2016;8:e2016025. [PMID: 27158438 DOI: 10.4084/MJHID.2016.025] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
147 Gavriilaki M, Sakellari I, Anagnostopoulos A, Gavriilaki E. The Impact of Antibiotic-Mediated Modification of the Intestinal Microbiome on Outcomes of Allogeneic Hematopoietic Cell Transplantation: Systematic Review and Meta-Analysis. Biol Blood Marrow Transplant 2020;26:1738-46. [PMID: 32447043 DOI: 10.1016/j.bbmt.2020.05.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
148 Jenq RR, Ubeda C, Taur Y, Menezes CC, Khanin R, Dudakov JA, Liu C, West ML, Singer NV, Equinda MJ, Gobourne A, Lipuma L, Young LF, Smith OM, Ghosh A, Hanash AM, Goldberg JD, Aoyama K, Blazar BR, Pamer EG, van den Brink MR. Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. J Exp Med 2012;209:903-11. [PMID: 22547653 DOI: 10.1084/jem.20112408] [Cited by in Crossref: 385] [Cited by in F6Publishing: 374] [Article Influence: 38.5] [Reference Citation Analysis]
149 Zama D, Bossù G, Leardini D, Muratore E, Biagi E, Prete A, Pession A, Masetti R. Insights into the role of intestinal microbiota in hematopoietic stem-cell transplantation. Ther Adv Hematol 2020;11:2040620719896961. [PMID: 32010434 DOI: 10.1177/2040620719896961] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
150 Shono Y, van den Brink MRM. Gut microbiota injury in allogeneic haematopoietic stem cell transplantation. Nat Rev Cancer 2018;18:283-95. [PMID: 29449660 DOI: 10.1038/nrc.2018.10] [Cited by in Crossref: 88] [Cited by in F6Publishing: 84] [Article Influence: 22.0] [Reference Citation Analysis]
151 Andermann TM, Rezvani A, Bhatt AS. Microbiota Manipulation With Prebiotics and Probiotics in Patients Undergoing Stem Cell Transplantation. Curr Hematol Malig Rep 2016;11:19-28. [PMID: 26780719 DOI: 10.1007/s11899-016-0302-9] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 5.7] [Reference Citation Analysis]
152 Krenger W, Ferrara JLM. Graft-versus-host disease and the Th1/Th2 paradigm. Immunol Res 1996;15:50-73. [DOI: 10.1007/bf02918284] [Cited by in Crossref: 114] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
153 de Gast GC, Gratama JW, Ringden O, Gluckman E. The multifactorial etiology of graft-versus-host disease. Immunology Today 1987;8:209-12. [DOI: 10.1016/0167-5699(87)90166-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
154 Barrett AJ. Graft-Versus-Host Disease: Basic Considerations. In: Schimpff SC, Klastersky J, editors. Infectious Complications in Bone Marrow Transplantation. Berlin: Springer Berlin Heidelberg; 1993. pp. 185-95. [DOI: 10.1007/978-3-642-84899-5_19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
155 Teshima T. The Pathophysiology of Graft-vs.-Host Disease. In: Ferrara J, Cooke K, Deeg H, editors. Graft vs. Host Disease, Third Edition. CRC Press; 2004. pp. 1-34. [DOI: 10.1201/b14165-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
156 Zeiser R, Blazar BR. Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy. N Engl J Med. 2017;377:2167-2179. [PMID: 29171820 DOI: 10.1056/nejmra1609337] [Cited by in Crossref: 369] [Cited by in F6Publishing: 238] [Article Influence: 73.8] [Reference Citation Analysis]
157 Marr KA, Seidel K, Slavin MA, Bowden RA, Schoch HG, Flowers MED, Corey L, Boeckh M. Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial. Blood 2000;96:2055-61. [DOI: 10.1182/blood.v96.6.2055.h8002055_2055_2061] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
158 Jenq RR, van den Brink MR. Antibiotic prophylaxis in allogeneic stem cell transplantation-what is the correct choice? Bone Marrow Transplant 2016;51:1071-2. [PMID: 27214076 DOI: 10.1038/bmt.2016.144] [Reference Citation Analysis]
159 Veenendaal D, de Boer F, Van der Waaij D. Effect of selective decontamination of the digestive tract of donor and recipient on the occurrence of murine delayed-type graft-versus-host disease. Med Microbiol Immunol 1988;177:133-44. [PMID: 3292884 DOI: 10.1007/BF00232893] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
160 Mapara MY, Sykes M. Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance. J Clin Oncol. 2004;22:1136-1151. [PMID: 15020616 DOI: 10.1200/jco.2004.10.041] [Cited by in Crossref: 218] [Cited by in F6Publishing: 91] [Article Influence: 12.1] [Reference Citation Analysis]
161 Markey KA, MacDonald KP, Hill GR. The biology of graft-versus-host disease: experimental systems instructing clinical practice. Blood. 2014;124:354-362. [PMID: 24914137 DOI: 10.1182/blood-2014-02-514745] [Cited by in Crossref: 109] [Cited by in F6Publishing: 108] [Article Influence: 13.6] [Reference Citation Analysis]
162 Poutsiaka DD. Editorial commentary: the gut microbiota strikes again. Clin Infect Dis 2015;61:358-60. [PMID: 25948062 DOI: 10.1093/cid/civ292] [Reference Citation Analysis]
163 Shono Y, van den Brink MRM. Empiric antibiotic use in allogeneic hematopoietic cell transplantation: should we avoid anaerobe coverage? Blood Adv 2017;1:2325-8. [PMID: 29296882 DOI: 10.1182/bloodadvances.2017005108] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
164 Mercadante AC, Perobelli SM, Alves AP, Gonçalves-Silva T, Mello W, Gomes-Santos AC, Miyoshi A, Azevedo V, Faria AM, Bonomo A. Oral combined therapy with probiotics and alloantigen induces B cell-dependent long-lasting specific tolerance. J Immunol 2014;192:1928-37. [PMID: 24453248 DOI: 10.4049/jimmunol.1301034] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
165 Holler E, Weber D. Fit for cure? Microbiota and GVHD. Blood 2016;128:2004-5. [PMID: 28157678 DOI: 10.1182/blood-2016-08-732156] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
166 Thiagarajan S, Neurath MF, Hildner K. Resolution of acute intestinal graft-versus-host disease. Semin Immunopathol 2019;41:655-64. [PMID: 31673757 DOI: 10.1007/s00281-019-00769-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
167 Uribe-Herranz M, Klein-González N, Rodríguez-Lobato LG, Juan M, de Larrea CF. Gut Microbiota Influence in Hematological Malignancies: From Genesis to Cure. Int J Mol Sci 2021;22:1026. [PMID: 33498529 DOI: 10.3390/ijms22031026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
168 Mcdonald GB, Shulman HM, Sullivan KM, Spencer GD. Intestinal and hepatic complications of human bone marrow transplantation. Part I. Gastroenterology 1986;90:460-77. [DOI: 10.1016/0016-5085(86)90949-2] [Cited by in Crossref: 214] [Cited by in F6Publishing: 170] [Article Influence: 5.9] [Reference Citation Analysis]
169 L�wenberg B, Vossen JMJJ, Dooren LJ. Transplantation of fetal liver cells in the treatment of severe combined immunodeficiency disease. Blut 1977;34:181-95. [DOI: 10.1007/bf00996167] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
170 Nalle SC, Turner JR. Endothelial and epithelial barriers in graft-versus-host disease. Adv Exp Med Biol 2012;763:105-31. [PMID: 23397621 DOI: 10.1007/978-1-4614-4711-5_5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
171 Ringdén O, Sadeghi B, Moretti G, Finnbogadottir S, Eriksson B, Mattsson J, Svahn BM, Remberger M. Long-term outcome in patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation. Int J Hematol 2018;107:478-85. [PMID: 29143281 DOI: 10.1007/s12185-017-2363-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
172 Song Y, Himmel B, Öhrmalm L, Gyarmati P. The Microbiota in Hematologic Malignancies. Curr Treat Options Oncol 2020;21:2. [PMID: 31927673 DOI: 10.1007/s11864-019-0693-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
173 Devaux CA, Million M, Raoult D. The Butyrogenic and Lactic Bacteria of the Gut Microbiota Determine the Outcome of Allogenic Hematopoietic Cell Transplant. Front Microbiol 2020;11:1642. [PMID: 32793150 DOI: 10.3389/fmicb.2020.01642] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
174 Zhao XC, Sun XY, Ju B, Meng FJ, Zhao HG. Acquired aplastic anemia: Is bystander insult to autologous hematopoiesis driven by immune surveillance against malignant cells? World J Stem Cells 2020;12:1429-38. [PMID: 33312408 DOI: 10.4252/wjsc.v12.i11.1429] [Reference Citation Analysis]
175 Nestel FP, Price KS, Seemayer TA, Lapp WS. Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease. J Exp Med 1992;175:405-13. [PMID: 1732411 DOI: 10.1084/jem.175.2.405] [Cited by in Crossref: 275] [Cited by in F6Publishing: 260] [Article Influence: 9.2] [Reference Citation Analysis]
176 Nolte MA, van der Meer JW. Inflammatory responses to infection: the Dutch contribution. Immunol Lett 2014;162:113-20. [PMID: 25455597 DOI: 10.1016/j.imlet.2014.10.007] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
177 Gale RP, Bortin MM, Bekkum DW, Biggs JC, Dicke KA, Gluckman E, Good RA, Hoffmann RG, Kay HEM, Kersey JH, Marmont A, Masaoka T, Rimm AA, Rood JJ, Zwaan FE. Risk factors for acute graft-versus-host disease. Br J Haematol 1987;67:397-406. [DOI: 10.1111/j.1365-2141.1987.tb06160.x] [Cited by in Crossref: 218] [Cited by in F6Publishing: 184] [Article Influence: 6.2] [Reference Citation Analysis]
178 Ma T, Chen Y, Li LJ, Zhang LS. Opportunities and Challenges for Gut Microbiota in Acute Leukemia. Front Oncol 2021;11:692951. [PMID: 34307157 DOI: 10.3389/fonc.2021.692951] [Reference Citation Analysis]
179 Guthery SL, Heubi JE, Filipovich A. Enteral metronidazole for the prevention of graft versus host disease in pediatric marrow transplant recipients: results of a pilot study. Bone Marrow Transplant. 2004;33:1235-1239. [PMID: 15077127 DOI: 10.1038/sj.bmt.1704474] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
180 Holler E, Landfried K, Meier J, Hausmann M, Rogler G. The role of bacteria and pattern recognition receptors in GVHD. Int J Inflam 2010;2010:814326. [PMID: 21188220 DOI: 10.4061/2010/814326] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
181 van Bekkum DW, Heidt PJ. The Role of the Microflora in Graft-versus-Host Disease After Allogeneic Bone Marrow Transplantation. In: de Vries RRP, Cohen IR, van Rood JJ, editors. The Role of Micro-organisms in Non-infectious Diseases. London: Springer; 1990. pp. 57-69. [DOI: 10.1007/978-1-4471-1796-4_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
182 Hong T, Wang R, Wang X, Yang S, Wang W, Gao Q, Zhang X. Interplay Between the Intestinal Microbiota and Acute Graft-Versus-Host Disease: Experimental Evidence and Clinical Significance. Front Immunol 2021;12:644982. [PMID: 33815399 DOI: 10.3389/fimmu.2021.644982] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
183 Hill GR, Ferrara JLM. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood 2000;95:2754-9. [DOI: 10.1182/blood.v95.9.2754.009k25_2754_2759] [Cited by in Crossref: 509] [Article Influence: 23.1] [Reference Citation Analysis]
184 Ehl S, Hombach J, Aichele P, Rülicke T, Odermatt B, Hengartner H, Zinkernagel R, Pircher H. Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8+ T cells to cause immunopathology. J Exp Med 1998;187:763-74. [PMID: 9480986 DOI: 10.1084/jem.187.5.763] [Cited by in Crossref: 129] [Cited by in F6Publishing: 120] [Article Influence: 5.4] [Reference Citation Analysis]
185 Ferrara JL, Reddy P. Pathophysiology of graft-versus-host disease. Semin Hematol. 2006;43:3-10. [PMID: 16412784 DOI: 10.1053/j.seminhematol.2005.09.001] [Cited by in Crossref: 237] [Cited by in F6Publishing: 214] [Article Influence: 14.8] [Reference Citation Analysis]
186 Amoureux MC. [Pathophysiological role of endotoxins, a common denominator to various diseases]. Pathol Biol (Paris) 2004;52:415-22. [PMID: 15336435 DOI: 10.1016/j.patbio.2004.04.017] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
187 Hill GR, Crawford JM, Cooke KR, Brinson YS, Pan L, Ferrara JL. Total Body Irradiation and Acute Graft-Versus-Host Disease: The Role of Gastrointestinal Damage and Inflammatory Cytokines. Blood 1997;90:3204-13. [DOI: 10.1182/blood.v90.8.3204] [Cited by in Crossref: 607] [Article Influence: 24.3] [Reference Citation Analysis]
188 Masetti R, Zama D, Leardini D, Muratore E, Turroni S, Prete A, Brigidi P, Pession A. The gut microbiome in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation. Pediatr Blood Cancer 2020;67:e28711. [PMID: 32939928 DOI: 10.1002/pbc.28711] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
189 Weber D, Hiergeist A, Weber M, Dettmer K, Wolff D, Hahn J, Herr W, Gessner A, Holler E. Detrimental Effect of Broad-spectrum Antibiotics on Intestinal Microbiome Diversity in Patients After Allogeneic Stem Cell Transplantation: Lack of Commensal Sparing Antibiotics. Clin Infect Dis 2019;68:1303-10. [PMID: 30124813 DOI: 10.1093/cid/ciy711] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 15.5] [Reference Citation Analysis]
190 McDonald GB, Bouvier M, Hockenbery DM, Stern JM, Gooley T, Farrand A, Murakami C, Levine DS. Oral beclomethasone dipropionate for treatment of intestinal graft-versus-host disease: a randomized, controlled trial. Gastroenterology 1998;115:28-35. [PMID: 9649455 DOI: 10.1016/s0016-5085(98)70361-0] [Cited by in Crossref: 64] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
191 Teshima T, Reddy P, Zeiser R. Acute Graft-versus-Host Disease: Novel Biological Insights. Biol Blood Marrow Transplant 2016;22:11-6. [PMID: 26453971 DOI: 10.1016/j.bbmt.2015.10.001] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 8.7] [Reference Citation Analysis]
192 Riwes M, Reddy P. Microbial metabolites and graft versus host disease. Am J Transplant 2018;18:23-9. [PMID: 28742948 DOI: 10.1111/ajt.14443] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
193 Mahmoud HK, Schaefer UW, Schüning F, Schmidt CG, Bamberg M, Haralambie E, Linzenmeier G, Hantschke D, Grosse-Wilde H, Luboldt W. Laminar air flow versus barrier nursing in marrow transplant recipients. Blut 1984;49:375-81. [PMID: 6388667 DOI: 10.1007/BF00319885] [Cited by in Crossref: 21] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
194 Haverman TM, Raber-Durlacher JE, Rademacher WM, Vokurka S, Epstein JB, Huisman C, Hazenberg MD, de Soet JJ, de Lange J, Rozema FR. Oral complications in hematopoietic stem cell recipients: the role of inflammation. Mediators Inflamm 2014;2014:378281. [PMID: 24817792 DOI: 10.1155/2014/378281] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
195 Kolb H. Hematopoietic stem cell transplantation and cellular therapy: KOLB. HLA 2017;89:267-77. [DOI: 10.1111/tan.13005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
196 Shin OS, Harris JB. Innate immunity and transplantation tolerance: the potential role of TLRs/NLRs in GVHD. Korean J Hematol 2011;46:69-79. [PMID: 21747878 DOI: 10.5045/kjh.2011.46.2.69] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
197 Adom D, Rowan C, Adeniyan T, Yang J, Paczesny S. Biomarkers for Allogeneic HCT Outcomes. Front Immunol 2020;11:673. [PMID: 32373125 DOI: 10.3389/fimmu.2020.00673] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
198 Hu L, Wang Q, Zhang X, Xu L, Wang Y, Yan C, Chen H, Chen Y, Liu K, Wang H, Huang X, Mo X. Positive stool culture could predict the clinical outcomes of haploidentical hematopoietic stem cell transplantation. Front Med 2019;13:492-503. [PMID: 30953261 DOI: 10.1007/s11684-019-0681-0] [Reference Citation Analysis]
199 Kohashi O, Kohashi Y, Takahashi T, Ozawa A, Shigematsu N. Reverse effect of gram-positive bacteria vs. gram-negative bacteria on adjuvant-induced arthritis in germfree rats. Microbiol Immunol 1985;29:487-97. [PMID: 2931580 DOI: 10.1111/j.1348-0421.1985.tb00851.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 37] [Article Influence: 1.4] [Reference Citation Analysis]
200 Vriesendorp HM, Heidt PJ. History of graft-versus-host disease. Experimental Hematology 2016;44:674-88. [DOI: 10.1016/j.exphem.2016.05.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
201 Peled JU, Hanash AM, Jenq RR. Role of the intestinal mucosa in acute gastrointestinal GVHD. Hematology Am Soc Hematol Educ Program 2016;2016:119-27. [PMID: 27913470 DOI: 10.1182/asheducation-2016.1.119] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
202 Ringdén O, Remberger M, Holmberg K, Edeskog C, Wikström M, Eriksson B, Finnbogadottir S, Fransson K, Milovsavljevic R, Omazic B, Svenberg P, Mattsson J, Svahn BM. Many days at home during neutropenia after allogeneic hematopoietic stem cell transplantation correlates with low incidence of acute graft-versus-host disease. Biol Blood Marrow Transplant 2013;19:314-20. [PMID: 23089563 DOI: 10.1016/j.bbmt.2012.10.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
203 Pereira AZ, Vigorito AC, Almeida AM, Candolo AA, Silva ACL, Brandão-Anjos AEP, Sá BL, Souza CLS, Castro Junior CG, Oliveira JSR, Barban JB, Mancilha EMB, Todaro J, Lopes LP, Macedo MCMA, Rodrigues M, Ribeiro PC, Silva RLD, Roberto TS, Rodrigues TCR, Colturato VAR, Paton EJA, Barros GMN, Almeida RDS, Moreira MCR, Flowers ME. Brazilian Nutritional Consensus in Hematopoietic Stem Cell Transplantation: Graft- versus -host disease. Einstein (Sao Paulo) 2020;18:eAE4799. [PMID: 32215466 DOI: 10.31744/einstein_journal/2020AE4799] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
204 Sullivan KM, Storb R. Allogeneic Marrow Transplantation. Cancer Investigation 2009;2:27-38. [DOI: 10.3109/07357908409020284] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
205 Storb R, Thomas ED. Allogeneic Bone-Marrow Transplantation. Immunol Rev 1983;71:77-102. [DOI: 10.1111/j.1600-065x.1983.tb01069.x] [Cited by in Crossref: 90] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
206 Koh AY. Potential for Monitoring Gut Microbiota for Diagnosing Infections and Graft-versus-Host Disease in Cancer and Stem Cell Transplant Patients. Clin Chem 2017;63:1685-94. [PMID: 28720679 DOI: 10.1373/clinchem.2016.259499] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
207 Epstein RJ, Mcdonald GB, Sale GE, Shulman HM, Thomas E. The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: A prospective study of thirteen patients. Gastroenterology 1980;78:764-71. [DOI: 10.1016/0016-5085(80)90681-2] [Cited by in Crossref: 153] [Cited by in F6Publishing: 94] [Article Influence: 3.6] [Reference Citation Analysis]
208 Biagi E, Zama D, Nastasi C, Consolandi C, Fiori J, Rampelli S, Turroni S, Centanni M, Severgnini M, Peano C, de Bellis G, Basaglia G, Gotti R, Masetti R, Pession A, Brigidi P, Candela M. Gut microbiota trajectory in pediatric patients undergoing hematopoietic SCT. Bone Marrow Transplant 2015;50:992-8. [PMID: 25893458 DOI: 10.1038/bmt.2015.16] [Cited by in Crossref: 66] [Cited by in F6Publishing: 71] [Article Influence: 9.4] [Reference Citation Analysis]
209 Harris RA. Bone marrow transplantation. In: Salaman JR, editor. Immunosuppressive Therapy. Dordrecht: Springer Netherlands; 1981. pp. 201-17. [DOI: 10.1007/978-94-011-7227-1_9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
210 Ferreira FM, Palle P, Vom Berg J, Prajwal P, Laman JD, Buch T. Bone marrow chimeras-a vital tool in basic and translational research. J Mol Med (Berl) 2019;97:889-96. [PMID: 31028417 DOI: 10.1007/s00109-019-01783-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
211 Chang CC, Hayase E, Jenq RR. The role of microbiota in allogeneic hematopoietic stem cell transplantation. Expert Opin Biol Ther 2021;21:1121-31. [PMID: 33412949 DOI: 10.1080/14712598.2021.1872541] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
212 Biedermann L, Rogler G. Environmental factors and their impact on the intestinal microbiota: a role for human disease? Dig Dis 2012;30 Suppl 3:20-7. [PMID: 23295688 DOI: 10.1159/000342590] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
213 Uryu H, Hashimoto D, Kato K, Hayase E, Matsuoka S, Ogasawara R, Takahashi S, Maeda Y, Iwasaki H, Miyamoto T, Saijo S, Iwakura Y, Hill GR, Akashi K, Teshima T. α-Mannan induces Th17-mediated pulmonary graft-versus-host disease in mice. Blood 2015;125:3014-23. [PMID: 25740827 DOI: 10.1182/blood-2014-12-615781] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 5.1] [Reference Citation Analysis]
214 Gerbitz A, Schultz M, Wilke A, Linde HJ, Schölmerich J, Andreesen R, Holler E. Probiotic effects on experimental graft-versus-host disease: let them eat yogurt. Blood 2004;103:4365-7. [PMID: 14962899 DOI: 10.1182/blood-2003-11-3769] [Cited by in Crossref: 121] [Cited by in F6Publishing: 110] [Article Influence: 6.7] [Reference Citation Analysis]